SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cadila Healthcare informs about company updates

06 Dec 2019 Evaluate

Cadila Healthcare has informed about inspection by USFDA of the company’s API manufacturing facility located at Dabhasa, Gujarat and company received an Establishment Inspection Report (EIR) which stated that the classification of the facility is ‘No Action Indicated (NAI)’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1112.00 12.35 (1.12%)
03-Jul-2026 09:57 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1908.75
Dr. Reddys Labs. 1369.20
Cipla 1464.25
Zydus Lifesciences 1112.00
Lupin 2447.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: